These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

699 related articles for article (PubMed ID: 15080299)

  • 21. The immunophenotypic stability of plasma cell myeloma by flow cytometry.
    Spears MD; Olteanu H; Kroft SH; Harrington AM
    Int J Lab Hematol; 2011 Oct; 33(5):483-91. PubMed ID: 21470371
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Utility of CD54, CD229, and CD319 for the identification of plasma cells in patients with clonal plasma cell diseases.
    Pojero F; Flores-Montero J; Sanoja L; Pérez JJ; Puig N; Paiva B; Bottcher S; van Dongen JJ; Orfao A;
    Cytometry B Clin Cytom; 2016 Jan; 90(1):91-100. PubMed ID: 26130131
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inability of a monoclonal anti-light chain antibody to detect clonal plasma cells in a patient with multiple myeloma by multicolor flow cytometry.
    van Velzen JF; van den Blink D; Bloem AC
    Cytometry B Clin Cytom; 2013; 84(1):30-2. PubMed ID: 23019187
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunophenotypic aberrations, DNA content, and cell cycle analysis of plasma cells in patients with myeloma and monoclonal gammopathies.
    Lima M; Teixeira Mdos A; Fonseca S; Gonçalves C; Guerra M; Queirós ML; Santos AH; Coutinho A; Pinho L; Marques L; Cunha M; Ribeiro P; Xavier L; Vieira H; Pinto P; Justiça B
    Blood Cells Mol Dis; 2000 Dec; 26(6):634-45. PubMed ID: 11358356
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CD138/syndecan-1: a useful immunohistochemical marker of normal and neoplastic plasma cells on routine trephine bone marrow biopsies.
    Chilosi M; Adami F; Lestani M; Montagna L; Cimarosto L; Semenzato G; Pizzolo G; Menestrina F
    Mod Pathol; 1999 Dec; 12(12):1101-6. PubMed ID: 10619261
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of surface and cytoplasmic immunoglobulin light/heavy chains by flow cytometry using a lysed-whole-blood technique: Implications for the differential diagnosis of B-cell malignancies.
    Babusíková O; Stevulová L
    Neoplasma; 2004; 51(6):422-30. PubMed ID: 15640950
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adhesion molecules on human myeloma cells: significant changes in expression related to malignancy, tumor spreading, and immortalization.
    Pellat-Deceunynck C; Barillé S; Puthier D; Rapp MJ; Harousseau JL; Bataille R; Amiot M
    Cancer Res; 1995 Aug; 55(16):3647-53. PubMed ID: 7543019
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CD20-negative low-grade B cell lymphoma showing immunophenotypic and genotypic features resembling plasma cell myeloma.
    Tabata R; Yasumizu R; Tabata C; Kojima M
    Pathol Res Pract; 2013 Jul; 209(7):459-62. PubMed ID: 23707547
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunophenotype of normal vs. myeloma plasma cells: Toward antibody panel specifications for MRD detection in multiple myeloma.
    Flores-Montero J; de Tute R; Paiva B; Perez JJ; Böttcher S; Wind H; Sanoja L; Puig N; Lecrevisse Q; Vidriales MB; van Dongen JJ; Orfao A
    Cytometry B Clin Cytom; 2016 Jan; 90(1):61-72. PubMed ID: 26100534
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neural cell adhesion molecule expression in plasma cells in bone marrow biopsies and aspirates allows discrimination between multiple myeloma, monoclonal gammopathy of uncertain significance and polyclonal plasmacytosis.
    Martín P; Santón A; Bellas C
    Histopathology; 2004 Apr; 44(4):375-80. PubMed ID: 15049904
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Correlation between serum levels of free light chain and phenotype of plasma cells in bone marrow in primary AL amyloidosis.
    Shimojima Y; Matsuda M; Gono T; Ishii W; Fushimi T; Hoshii Y; Yamada T; Ikeda S
    Amyloid; 2005 Mar; 12(1):33-40. PubMed ID: 16076609
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Review of phenotypic markers used in flow cytometric analysis of MGUS and MM, and applicability of flow cytometry in other plasma cell disorders.
    Raja KR; Kovarova L; Hajek R
    Br J Haematol; 2010 May; 149(3):334-51. PubMed ID: 20201947
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasma cells in peripheral blood stem cell harvests from patients with multiple myeloma are predominantly polyclonal.
    Pope B; Brown R; Gibson J; Joshua D
    Bone Marrow Transplant; 1997 Aug; 20(3):205-10. PubMed ID: 9257888
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Utility of CD56 immunohistochemical studies in follow-up of plasma cell myeloma.
    Harrington AM; Hari P; Kroft SH
    Am J Clin Pathol; 2009 Jul; 132(1):60-6. PubMed ID: 19864234
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CD19-CD45 low/- CD38 high/CD138+ plasma cells enrich for human tumorigenic myeloma cells.
    Kim D; Park CY; Medeiros BC; Weissman IL
    Leukemia; 2012 Dec; 26(12):2530-7. PubMed ID: 22733078
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Flow cytometric immunophenotyping of plasmacytic neoplasms.
    DiGiuseppe JA
    Am J Clin Pathol; 2007 Feb; 127(2):172-4. PubMed ID: 17210527
    [No Abstract]   [Full Text] [Related]  

  • 37. A novel multiparametric approach for analysis of cytoplasmic immunoglobulin light chains by flow cytometry.
    Chang CC; Schur BC; Kampalath B; Lindholm P; Becker CG; Vesole DH
    Mod Pathol; 2001 Oct; 14(10):1015-21. PubMed ID: 11598172
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The phenotype of normal, reactive and malignant plasma cells. Identification of "many and multiple myelomas" and of new targets for myeloma therapy.
    Bataille R; Jégo G; Robillard N; Barillé-Nion S; Harousseau JL; Moreau P; Amiot M; Pellat-Deceunynck C
    Haematologica; 2006 Sep; 91(9):1234-40. PubMed ID: 16956823
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetic abnormalities and patterns of antigenic expression in multiple myeloma.
    Mateo G; Castellanos M; Rasillo A; Gutiérrez NC; Montalbán MA; Martín ML; Hernández JM; López-Berges MC; Montejano L; Bladé J; Mateos MV; Sureda A; de la Rubia J; Díaz-Mediavilla J; Pandiella A; Lahuerta JJ; Orfao A; San Miguel JF
    Clin Cancer Res; 2005 May; 11(10):3661-7. PubMed ID: 15897562
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Marginal zone B cell lymphomas with extensive plasmacytic differentiation are neoplasms of precursor plasma cells.
    Meyerson HJ; Bailey J; Miedler J; Olobatuyi F
    Cytometry B Clin Cytom; 2011 Mar; 80(2):71-82. PubMed ID: 21337490
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 35.